Float Short %

0.55

Margin Of Safety %

Put/Call OI Ratio

0.4

EPS Next Q Diff

0.1

EPS Last/This Y

EPS This/Next Y

0.57

Price

74.21

Target Price

86.96

Analyst Recom

1.45

Performance Q

17.08

Relative Volume

0.66

Beta

0.43

Ticker: AZN

21 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-01-23	AZN	68.61	0.53	0.21	124171
2025-01-24	AZN	69.06	0.53	0.10	125169
2025-01-27	AZN	69.99	0.54	1.91	126116
2025-01-28	AZN	69.61	0.58	0.07	131356
2025-01-29	AZN	70.24	0.52	0.27	140625
2025-01-30	AZN	71.23	0.50	0.37	148714
2025-01-31	AZN	70.77	0.50	0.10	150256
2025-02-03	AZN	69.86	0.51	0.41	141431
2025-02-04	AZN	68.97	0.50	0.92	144597
2025-02-05	AZN	70.93	0.51	0.32	148834
2025-02-06	AZN	72.41	0.47	0.13	166973
2025-02-07	AZN	72	0.42	0.62	186568
2025-02-10	AZN	72.65	0.41	0.07	179668
2025-02-11	AZN	72.72	0.38	0.12	191475
2025-02-12	AZN	74.45	0.38	0.36	195067
2025-02-13	AZN	74.42	0.39	0.21	195015
2025-02-14	AZN	73.59	0.38	0.11	205802
2025-02-18	AZN	74.79	0.39	0.07	200205
2025-02-19	AZN	73.81	0.37	0.12	210978
2025-02-20	AZN	74.57	0.36	0.01	212192
2025-02-21	AZN	74.22	0.40	0.44	200861
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

21 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-01-23	AZN	68.60	50.9	5509.1	4.15
2025-01-24	AZN	69.07	50.9	5617.2	4.15
2025-01-27	AZN	70.08	50.9	5769.2	4.15
2025-01-28	AZN	69.60	50.9	5401.8	4.15
2025-01-29	AZN	70.23	50.9	5532.8	4.15
2025-01-30	AZN	71.24	50.9	5674.2	4.15
2025-01-31	AZN	70.76	48.1	5334.6	4.15
2025-02-03	AZN	69.86	48.1	5163.7	4.15
2025-02-04	AZN	68.95	48.1	5052.8	4.15
2025-02-05	AZN	70.93	48.1	5716.2	4.15
2025-02-06	AZN	72.36	48.1	5824.6	4.15
2025-02-07	AZN	72.01	48.1	5048.7	4.15
2025-02-10	AZN	72.66	48.1	-	4.64
2025-02-11	AZN	72.72	48.1	-	4.49
2025-02-12	AZN	74.45	48.1	-	4.49
2025-02-13	AZN	74.43	48.1	-	4.49
2025-02-14	AZN	73.58	48.1	-	4.47
2025-02-18	AZN	74.79	5.6	-	4.47
2025-02-19	AZN	73.81	5.6	-	4.47
2025-02-20	AZN	74.57	5.6	5239.0	4.47
2025-02-21	AZN	74.21	5.6	5559.4	4.47
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-01-23	AZN	0.00	-0.47	0.41
2025-01-24	AZN	0.00	-0.47	0.41
2025-01-27	AZN	0.00	-0.48	0.41
2025-01-28	AZN	0.00	-0.48	0.49
2025-01-29	AZN	0.00	-0.48	0.49
2025-01-30	AZN	0.00	-0.48	0.49
2025-01-31	AZN	0.00	-0.48	0.49
2025-02-03	AZN	0.00	-0.47	0.49
2025-02-04	AZN	0.00	-0.47	0.49
2025-02-05	AZN	0.00	-0.47	0.49
2025-02-06	AZN	0.00	-0.47	0.49
2025-02-07	AZN	0.00	-0.47	0.49
2025-02-10	AZN	0.00	-1.72	0.49
2025-02-11	AZN	0.00	-1.72	0.49
2025-02-12	AZN	0.00	-1.72	0.55
2025-02-13	AZN	0.00	-1.72	0.55
2025-02-14	AZN	0.00	-1.72	0.55
2025-02-18	AZN	0.00	-1.67	0.55
2025-02-19	AZN	0.00	-1.67	0.55
2025-02-20	AZN	0.00	-1.67	0.55
2025-02-21	AZN	0.00	-1.67	0.55
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

1.05

Avg. EPS Est. Current Quarter

1.09

Avg. EPS Est. Next Quarter

1.15

Insider Transactions

Institutional Transactions

-1.67

Beta

0.43

Average Sales Estimate Current Quarter

13754

Average Sales Estimate Next Quarter

14104

Fair Value

80.24

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

15.4

Max Drawdown 5-Year %

-27.9

Target Price

86.96

P/E

32.93

Forward P/E

14.66

PEG

2.95

P/S

4.26

P/B

5.64

P/Free Cash Flow

22.39

EPS

2.25

Average EPS Est. Cur. Y

4.47

EPS Next Y. (Est.)

5.04

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

13.01

Relative Volume

0.66

Return on Equity vs Sector %

-2

Return on Equity vs Industry %

-9.7

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.29

EBIT Estimation

5559.4

Astrazeneca PLC

Sector: Healthcare

Industry: Drug Manufacturers - General

Employees: 94300

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Lokelma, Roxadustat, Andexxa, Crestor, Seloken, Onglyza, Bydureon, Fasenra, Breztri, Symbicort, Saphnelo, Tezspire, Pulmicort, Bevespi, and Daliresp for cardiovascular, renal, metabolism, and oncology. Its marketed products also comprise Vaxzevria, Beyfortus, Synagis, FluMist, Soliris, Ultomiris, Strensiq, Koselugo, and Kanuma for covid-19 and rare disease. The company serves primary care and specialty care physicians through distributors and local representative offices in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia. It has a collaboration agreement with Neurimmune AG to develop and commercialize NI006; BenevolentAI for drug discovery for systemic lupus erythematosus; Lunit for developing AI-Powered Digital Pathology Risk Assessment Tools for NSCLC; and Absci Corporation for AI-driven drug discovery against an oncology target. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.

stock quote shares AZN – AstraZeneca PLC Stock Price stock today

news today AZN – AstraZeneca PLC stock forecast ,stock prediction 2023 2024 2025

marketwatch AZN – AstraZeneca PLC yahoo finance google finance

stock history AZN – AstraZeneca PLC invest stock market

stock prices AZN premarket after hours

ticker AZN fair value insiders trading

Investment involves risk. As a general rule, you should only trade in financial products that you are familiar with and understand the risk associated with them. The risk warning described in each financial product below is not exhaustive, you should carefully consider your investment experience, financial situation, investment objective, risk tolerance level and consult your independent financial adviser as to the suitability of your situation prior making any investment.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: AZN

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Get Started

About

Last Quarter Act. EPS

Average EPS Est. Cur. Y